Parasites often cause serious outbreaks of disease in farmed fish. The present study is the first to describe the antiparasitic efficacy of Acriflavine on Oreochromis niloticus parasitized with Centrocestus formosanus metacercariae and Trichodina centrostrigeata protozoa. A total of 550 O. niloticus suffering from respiratory distress were collected from a fish farm. Clinical and parasitological examinations of 150 fish revealed a mixed infestation with Centrocestus formosanus and Trichodina centrostrigeata. The median lethal dose (LC50) of Acriflavine (5, 10, 25, 50, & 100 mg/L) was calculated against 160 healthy O. niloticus. Results revealed that the 12 h and 96 h LC50 of Acriflavine was 114.61 and 35.196 mg/L. Further, an experimental design consisting of three fish groups was used to assess the efficacy of Acriflavine (10 mg/L, long-term bath) against Centrocestus formosanus- and Trichodina centrostrigeata-infested fish; the first group was treated with Acriflavine (treated fish), the second group was not treated (nontreated fish) and the third group was healthy fish (negative control). Acriflavine was effective against Centrocestus formosanus and Trichodina centrostrigeata, reducing the mean intensity of parasites by 91.1% and 95.6%, respectively, compared with infested fish (nontreated). Moreover, treated fish exhibited restoration of normal gill histoarchitecture and normal central cartilaginous support after treatment. Treated O. niloticus also showed significant downregulation of inflammatory-related enzyme (Cox-2) and pro-inflammatory cytokine (IL-1ß) genes compared with infested fish, as well as a significant reduction in lipid peroxidation (LPO) levels. Acriflavine provides a safe and efficient treatment for controlling Centrocestus formosanus metacercariae and Trichodina centrostrigeata protozoans, improving the health, productivity and welfare of Oreochromis niloticus.
Read full abstract